“Survival is not the goal, transformative success is.”

https://www.siliconindia.com/digital-magazine/patent-and-trademark-law-services-july-2021/#page=23

Poonam Raghuvanshi Founder Analysing and strategizing Intellectual property has become relatively simpler today, with the help of Patent and Trademark service providers in the market. ipEssentia is a boutique Intellectual Property firm with freshly brewed enthusiasm, empowered by decades of experience in building & leading the in-house Intellectual Property functions of multinational companies. The company […]

The U.S. Supreme Court denied taking up Sandoz’s petition for it to review earlier decisions that had favoured Amgen in the long-running patent litigation. Biosimilar Etanercept is now barred until 2029 in the US. In 2019, New Jersey federal district court ruled in favor of the Amgen, though Sandoz appealed, the U.S. Court of Appeals […]

Once again in Bayer Healthcare LLC v. Baxalta Inc. (Fed. Cir. 2021), the jury awarded Bayer reasonable royalty damages, based on a certain (17.78%) royalty rate for Defendants’ profits. The jury selected a rate between the range presented by the damages expert. The damages expert used a “reliable methodology for determining the range of possible […]

We were recently looking at the European patent landscape of a product for Relapsing-remitting multiple sclerosis (RRMS). There are several divisional patents & patent applications which are part of the core composition patent family and are at various stages of prosecution or opposition (some are revoked & under appeal). While the parent patent was revoked, […]

Pharma clients normally ask for product identification. Product identification is an elaborate process and one needs to go stepwise, whether identification is for generic dosage form or active pharmaceutical ingredient (API). Identification process starts with understanding client’s objectives, current portfolio, current capabilities (both from R&D and Marketing penetration perspective), budget & strategic goals. Next step […]

After a patent has been issued, the owner has the power to enforce the patent. However, Patents are territorial rights, their scope, enforcement, and validity may vary from country to country. Differences in governing laws/rules applied to various aspects of patent litigation like claim construction; recovery of damages; availability of interim remedies to provide emergency […]

What’s your game? Most of the businesses are becoming global and technology-driven, companies everywhere are facing pressures to be on the cutting edge. And this is not just true for the small pharma companies even the largest pharmaceutical companies are facing the same issues. Additionally, During the last decade, Pricing and early access to promising […]

Commercial success of pharmaceutical products is subject to several risks, like reliance on third parties, regulatory compliance, failure to gain market and patient acceptance, ability to provide adequate supply, competitive challenges, legal and regulatory requirements, and intellectual property and regulatory challenges. The commercial success depends, in part, on company’s ability to obtain patents and/or maintain […]

Dec 4th, 2020, in Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] the England and Wales High Court (Patents Court) rejected all the claims of Mylan for the invalidity of the EP1,441,702. The case has been in headlines, since June 2020 when the UK appeals court refused the grant of […]